Clinical Trial

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Name: A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies — clinical trial record (NCT06906380)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study will evaluate the long-term safety of ARD103 cellular therapies

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-26.

Trial Details

NCT Number	NCT06906380
Lead Sponsor	ARCE Therapeutics, Inc.
Conditions	Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapsed or Refractory, MDS (Myelodysplastic Syndrome)
Enrollment	49 participants
Start Date	2026-03-15
Primary Completion	2040-05-30 (estimated)
Study Completion	2040-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-08